It is surprising that a "high profile fundie" is so ignorant of the usual evolutionary path of a biotech, requiring many years of expensive trials and little balancing income. And only a minority of those have successful P3 trials and FDA imprimatur.
ALL developing biotechs are valuation bubbles, with prices based on hope. The fundie told us nothing about MSB.
MBS is a minute before a bright dawn on this evolutionary trail. The fundie is confusing price with value. He is bewitched by the market's siren song and can't hear Silviu's sweet notes. The job is almost done.
It is surprising that a "high profile fundie" is so ignorant of...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |